August 13, 2020

The Niche

Knoepfler lab stem cell blog

stem cell treatment

2 min read

Many stem cell clinics are in a bind in 2017 in the new RMAT approval reality. Stem cell clinics say that they only want to help people by providing stem cell therapies to patients in a speedier way that they claim getting FDA approval for a trial just doesn’t allow, but that doesn’t ring true. It never has and now even less so. The new RMAT designation out there based on the 21st Century Cures Act whereby the FDA can rapidly accelerate truly promising …Read More

2 min read

One of my Top 20 Predictions for Stem Cells for 2017 was that we’d see more instances of fake stem cell news. One type of stem cell fake news consists of promotional press releases that seek to recruit paying customers for unproven stem cell “treatments” based on made up or exaggerated claims about safety and efficacy or about the stem cell clinic’s credentials. Another kind of fake stem cell news is more ideologically based and is mainly practiced by anti-embryonic stem cell (ESC) websites …Read More

1 min read

What were the top posts here on The Niche for the past year? I’ve listed some of them below along with some posts from 2015 that remain highly read. Some top 2016 posts 20 Nominees for Stem Cell Person of the Year 2016 Award REGROW Act is Attack on Science-Based Stem Cell Trial Oversight Will new gene editing tech NgAgo challenge CRISPR? FDA Warning Letter to Irvine Stem Cell Treatment Center Clinics Across US Public stem cell skirmish erupts between Hanna & Jaenisch Controversy over …Read More

3 min read

Each year I make a list of predictions for the stem cell and regenerative medicine field for the coming new year. Later in this post I list my top 20 stem cell predictions for 2017. In looking at my past predictions I realized this will now be my 7th year doing stem cell/regenerative medicine yearly predictions. You can see below links to these predictions for past years, which sometimes seems rather far removed from today and in other cases strike me as strangely apropos of …Read More